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Background and Purpose—The volume of T2-hyperintense white matter (HWM) is an important neuroimaging marker
of cerebral integrity with a demonstrated high heritability. Pathophysiology studies have shown that the regional,
ependymal, and subcortical HWM lesions are associated with elevated arterial pulse pressure and arterial blood pressure
(BP), respectively. We performed bivariate, whole-genome linkage analyses for HWM volumes and BP measurements
to identify chromosomal regions that contribute jointly to both traits in a population of healthy Mexican Americans. Our
aims were to localize novel quantitative trait loci acting pleiotropically on these phenotypes and to replicate previous
genetic findings on whole brain HWM volume and BP measurements.
Methods—BP measurements and volumes of whole-brain (WB), subcortical, and ependymal HWM lesions, measured
from high-resolution (1 mm3) 3-dimensional fluid-attenuated inversion recovery images, served as focal quantitative
phenotypes. Data were collected from 357 (218 females; mean age47.913.2 years) members of large extended
families who participated in the San Antonio Family Heart Study.
Results—Bivariate genomewide linkage analyses localized a significant quantitative trait locus influencing WB and
regional (ependymal) HWM volumes and pulse pressure and systolic BP to chromosomal location 1q24 between
markers D1S196 and D1S1619. Several other chromosomal regions (1q42, 10q24-q26, and 15q26) exhibited suggestive
linkages. The results of the post hoc analyses that excluded 55 subjects taking antihypertensive medication showed no
substantive differences from the results obtained in the full cohort.
Conclusion—This study confirms several previously observed quantitative trait loci influencing BP and cerebral integrity and
identifies a novel significant quantitative trait locus at chromosome 1q24. The genetic results strongly support a role for
pleiotropically acting genes jointly influencing BP and cerebral white matter integrity. (Stroke. 2010;41:2137-2142.)
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The volume of T2-hyperintense white matter (HWM)lesions1 is an important neuroimaging marker of cerebral
integrity with a large (55% to 73%) proportion of its
intersubject variability attributed to genetic factors.2–5 In-
creases in HWM volume are correlated with a decline in
cerebral blood flow,6 glucose metabolism,7 and cognition.8,9
Histopathologically, HWM lesions represent regions of accu-
mulation of extracellular water due to focal degradation of the
myelin sheath that arise from at least 2 distinct pathogenic
mechanisms.10 Ependymal lesions are the regions of periven-
tricular gliosis and are thought to be produced by mechanical
damages caused to the ependymal lining by the pulsatile
movements of cerebrospinal fluid, a mechanism known as
pulse-wave encephalopathy.11 The amplitude of the pulsatile
cerebrospinal fluid movements is linked to the pulse pressure
(PP), the difference among arterial, systolic blood pressure
(SBP)m and diastolic blood pressure (DBP). Elevated PP was
shown to be associated with higher ependymal HWM vol-
umes, even in normotensive individuals.12,13 In contrast,
subcortical HWM lesions are predominantly the regions of
focal cerebral ischemia that are associated with elevated SBP
and are thought to be the product of age-related stenosis and
loss of permeability of capillaries due to small vessel
disorders.10,11
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Recent findings by Turner and colleagues4 have identified
overlap between genetic loci for the whole-brain (WB) HWM
volume and blood pressure (BP) measurements in 488 hyper-
tensive sibships.4 Turner and colleagues used bivariate,
whole-genome linkage analyses to identify several significant
and suggestive loci for WB HWM and BP measurements,
suggesting a high degree of pleiotropy between these traits. In
the current article, we pursued to replicate findings by Turner
and colleagues4 using bivariate linkage analysis for WB
HWM volume and BP measurements. We performed these
analyses in a well-studied population of randomly selected
Mexican American families. Our previous research in this
population demonstrated significant heritability for HWM
volumes and BP traits (Table 1) and showed that the 2
regional HWM volumes shared only a moderate (approxi-
mately 21%; G.460.12;P0.001) fraction of the genetic
variance.5,14 Furthermore, we demonstrated that although the
univariate linkage analyses for the HWM and BP traits did
not produce statistically significant loci, these analyses have
independently showed a locus of suggestive significance on
chromosome 1, q24.5,14 An additional aim of this article is to
formally test the significance of the overlap between the
genes influencing the volume of HWM lesions and those
determining the individual variability in arterial BP on
chromosome 1 using a bivariate linkage analysis. A bivariate
analysis can reveal chromosomal regions that contribute
jointly to both traits either through the pleiotropic effects of
the same genetic variants or the coincidental effects of closely
linked genes.4 Bivariate analysis also greatly improves the
power of genetic discovery and the ability to localize causal
beyond what is possible by univariate linkage analyses.4
Methods
Subjects and Measurements
Three hundred fifty-seven (218 females) active participants in the
San Antonio Family Heart Study15 were recruited as the part of this
study. The Mexican American individuals are from large extended
pedigrees selected randomly from the community. Subjects ranged in
age from 19 to 85 years of age (47.913.2 years) and were part of
47 families (9.38.1 individuals/family; range, 2 to 38). Subjects
were excluded for MRI contraindications, history of neurological
illnesses, or major neurological event (stroke). At the time of the
collection of BP measurements, 122 subjects (77 females; average
age54.813.0) were self-reported to have hypertension and 55
subjects (41 female, average age 58.512.0 years) were reported to
take antihypertensive medications. Additionally, 65 subjects were
reported to have Type II diabetes and 13 subjects were reported to
have heart disorders. To reduce the possible confounding effects of
the antihypertensive drugs, we repeated all analyses in a cohort that
excluded these subjects. This smaller cohort, after removing these
individuals, consisted of 302 subjects (177 females) with the average
age of 46.312.7 years and exhibited only slightly lower average
SBP (12016.4), DBP (70.110.6), and PP (50.513.9) values
than those of the full cohort (Table 1). All subjects provided written
informed consent on forms approved by the Institutional Review
Board of the University of Texas Health Science Center at San
Antonio (UTHSCSA).
Collection of the SBP and DBP measurements was detailed in
Rutherford et al.14 In short, SBP and DBP measurements were
performed using a random-zero sphygmomanometer on the left arm.
Three measurements were performed with 5-minute intervals and
average of the last measurements was used as trait values. PP was
calculated as the difference between SBP and DBP. Brain imaging
and image analysis procedures were described in detail elsewhere.5
Brain images were collected an average of 3.00.8 years (maxi-
mum5.3 years) after the BP measurements. Hence, there is a
prospective element to the brain measures. Imaging was performed
at the Research Imaging Institute, UTHSCSA, using a Siemens 3-T
Trio scanner and a high-resolution 8-channel head coil. Three-
dimensional, T2-weighted imaging data were acquired using a
high-resolution (isotropic 1 mm), turbo-spin-echo fluid-attenuated in-
version recovery sequence with the following parameters: TR/TE/TI/
flip angle/echo train length5 seconds/353 ms/1.8 s/180°/221. Fluid-
attenuated inversion recovery images were preprocessed by removal of
nonbrain tissue, registration to the Talairach frame, and RF inhomoge-
neity correction. HWM regions were manually delineated in
3-dimensioal space using in-house software (http://ric.uthscsa.edu/
mango) by an experienced neuroanatomist with high (r2 0.9) test–
retest reproducibility. HWM regions were coded as ependymal regions,
contiguous with cerebrospinal fluid structures, and subcortical in accor-
dance with a technique described in Kochunov et al5 and Henry Feugeas
et al.16 The WB HWM volume and the volumes of subcortical and
ependymal HWM were measured for each subject.
Genotyping
The details of the genotyping procedure can be found in Kammerer
et al.17 After DNA was extracted from lymphocytes, fluorescently
labeled primers from the MapPairs Human Screening set (Versions
6 and 8; Research Genetics, Huntsville, Ala) and polymerase chain
reaction were used to amplified 417 microsatellite markers spaced at
approximately 10-cM intervals across 22 autosomes. An automated
DNA sequencer (ABI Model 377 with Genescan and Genotyper
software; Applied Biosystems, Foster City, Calif) was used. The
average heterozygosity index for these markers was approximately
0.76. The sex-averaged marker map was confirmed by deCODE
genetics and markers not on this map were placed by interpolation
based on physical location.18
Bivariate, Quantitative Trait Linkage Analysis
Quantitative genetic analyses were performed using a variance
components methods implemented in SOLAR (sequential oligogenic
linkage analysis routines).19 Bivariate quantitative trait linkage
analyses of HWM volumes and BP traits were performed to localize
Table 1. Heritability (h2) Estimates and the Pattern of Significant Covariance for the WB and Regional HWM Volumes
and 3 BP Measurements





WB HWM 2.502.81 cm3 .72 1E-14 Age (5E-14) 28%
Subcortical HWM .611.34 cm3 .66 4E-11 Age (3E-16) 27%
Ependymal HWM 1.842.07 cm3 .73 1E-9 Age (2E-9) 20%
SBP 122.616.6 mm Hg .63 1E-6 Age (1E-3) 11%
DBP 71.310.8 mm Hg .17 .04 None 0%
PP 51.314.2 mm Hg .49 1E-4 Age (1E-3), age2 (1E-4) 23%
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potential quantitative trait loci (QTLs) influencing phenotypic vari-
ation to specific chromosomal locations.19 Model parameters were
estimated using maximum likelihood. The hypothesis of significant
linkage was assessed by comparing the likelihood of a classical
additive polygenic model with that of a model allowing for both a
polygenic component and a variance component due to linkage at a
specific chromosomal location. The logarithm of odds (LOD) score
given by the log10 of the ratio of the likelihood of the linkage and the
polygenic model served as the test statistic for genetic linkage.
Because unmodified bivariate LOD scores typically involve an extra
degree of freedom, we calculated the single locus equivalent LOD
for each bivariate localization test. We chose LOD scores of 2.0 and
3.0 as the minimal requirements for the suggestive (likely to occur
1 times by chance in a genome scan) and significant scores
(genomewide probability value0.05), respectively. Similar to pre-
vious studies, HWM volumes and BP measurements were trans-
formed using the inverse Gaussian transformation to assure normal
range for kurtosis and skewness.2–4 All genetic analyses were
conducted with age, sex, age*sex, age2, age2*sex, and diagnostic
status for Type 2 diabetes and heart disorder (encoded as 0 or 1)
included as covariates.
Results
Bivarate, genomewide linkage analyses produced 3 signifi-
cant (LOD 3.0) and several suggestive (LOD 2.0) QTL
localizations (Figure; Table 1). The highest LOD score
(LOD3.82) was observed for the WB HWM and PP
analysis at the chromosomal location 1q24, located 200 cM
away from the p-terminus (Table 1). A significant linkage
(LOD3.19) was also observed at this same location for the
ependymal HWM volume and PP. Additionally, a significant
linkage (LOD3.07) between WB HWM volume and SBP
was also observed at this location (Figure; Table 1). Bivariate
analysis for sublobar HWM volume and BP measurements
only reached suggestive levels of significance (Table 1).
The highest score (LOD2.68) was observed for SBP at
chromosomal location 10q24-q26, located 15 cM away
from the p-terminus (Table 1). Additionally, a suggestive
linkage site was observed for both regional HWM mea-
surements and SBP at the region of chromosome 15q26
(Table 1). There were no significant linkage results for any
of the analyses that involved DBP, but a suggestive linkage
site was identified on chromosome 10 for both regional
HWM volume traits (Table 1).
The results of the post hoc analyses that excluded subjects
taking antihypertensive medication showed no substantive
differences from the results in the full cohort (Table 2). There
were no new significant or suggestive genetic loci observed
in the smaller cohort and there were only minute differences
in the significance of the peaks. We observed a slight (but
nonsignificant) increase in the LOD scores for the ependymal
and PP and WB and SBP analyses, from 3.19 to 3.40 and 3.07
to 3.14, respectively. We also observed a slight (nonsignifi-
cant) reduction in the significance for the WB and PP 3
analysis from 3.82 to 3.62.
Figure. Bivariate linkage analysis results for WB (top), ependymal (middle), and subcortical (bottom) HWM volumes (bottom) and 3
measurements of arterial BP.
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Our study in healthy Mexican Americans individuals aimed
to replicate a finding of shared genetic loci between HWM
and quantitative BP traits, previously reported by Turner et
al4 in a study of hypertensive sibships. We performed these
analyses in a cohort of well-characterized population of
Mexican Americans. Additional, post hoc analyses were
performed in a cohort that excluded subjects taking antihy-
pertensive medications. The genetic linkage analyses in both
cohorts identified the same regions of significant and sugges-
tive linkage and these loci overlapped with several loci
reported by Turner and colleagues and with several loci
previously identified by the univariate linkage analyses of
BP, triglyceride levels, and atherosclerosis traits performed
by this and other groups. The highest linkage value
(LOD3.82/3.62 full versus normotensive cohorts) was ob-
served for the bivariate linkage analysis of WB HWM
volume and PP. This locus (chromosome 1q24) was also
significant in the bivariate analyses of the WB HWM and
SBP and ependymal HWM and PP (Table 2). This locus
(1q24) was previously identified by our group as a suggestive
locus as a part of the univariate analysis of SBP.14 It is known
to harbor the constellation of selectin genes (SELP, SELL,
and SELE) and also the coagulation factor V (F5) gene. In
particular, the adhesion molecule P-selectin is a marker of
potential endothelial dysfunction that has been implicated as
a risk factor in essential hypertension20,21 and stroke.20,22
Additionally, platelet-derived gene expression levels of SELP
have been observed to be strongly and positively correlated
with arterial BP.18,23 This finding was replicated in our
population, in which we observed a highly significant, posi-
tive correlation between SELP mRNA expression levels and
arterial BP.24 No other gene transcripts in this region exhib-
ited such a strong relationship with BP. Therefore, SELP
appears to be a strong positional candidate gene that may be
responsible for the significant QTLs on chromosome 1.
Furthermore, deep sequencing and functional variants analy-
ses will be required for true identification.
Locations of 2 suggestive linkages identified by this study
overlapped with locations of suggestive linkage reported by
Turner et al.4 The first overlap was observed for the region on
the chromosome 15, q26 (94 cM), where Turner and col-
leagues observed a suggestive QTL for the bivariate analysis
of the WB HWM and mean BP. This region was previously
shown to be strongly associated with hypertension and
regulation of blood lipids by the genomewide association
analyses of triglyceride levels.23,24 The second overlap was
observed for the region on the chromosome 1q42 (272 cM),
where Turner and colleagues observed a suggestive QTL for
the bivariate analysis of WB HWM and PP. This region
harbors the angiotensinogen gene and was previously impli-
cated by a whole-genome linkage study in hypertensive
individuals.25
However, we were unable to replicate findings by Turner
and colleagues of the significant QTL on chromosomes 5 (95
cM) and 11(19 cM). Indeed, at these chromosomal locations,
our peak LOD scores were only approximately 0.1 to 0.3
(Figure). That lack of complete overlap in genetic loci
between these 2 studies could be due several potential issues.
Like with all complex disease genetic studies, power to
localize such pleiotropic genetic effects can be limited and
lead to discrepancies between studies. More fundamentally,
genetic factors vary across different ethnicities. The study by
Turner and colleagues was focused on populations of Euro-
pean ancestry, whereas our study is the first to examine
Mexican Americans, a population with significant Native
American admixture. If relatively rare variants are involved
in the determination of quantitative variability, we may
expect considerable differences in the localization of the most
important genetic loci across populations.26 Linkage studies
of such complex phenotypes cannot be used to exclude
genetic regions for important QTLs. Therefore, the lack of
concordance cannot be interpreted as evidence against the
hypothesis that a QTL exists in a particular genomic region.
Additionally, although we identified no significant genomic
regions showing joint effects on DBP and HWM volumes, we
cannot rule such loci out. Similarly, the lack of identification
of genomic regions jointly influencing 2 phenotypes provides
no evidence on their overall pleiotropic relationship.
Our findings supported the hypothesis that ependymal and
subcortical white matter lesions may have different causal
genetic loci.5,11,16,27 We previously showed that ependymal
and subcortical HWM volumes shared only 21% of genetic
variance, which suggested that most of the genetic variation is
nonoverlapping.5 In agreement with the pulse-wave enceph-
alopathy mechanism of formation of the ependymal lesions,
the linkage results for the bivariate, ependymal HWM volume
and PP reached statistical significance (LOD3.19). The
linkage results for the subcortical HWM volume only reached
suggesting significance, but the highest LOD score
(LOD2.68) was observed for the bivariate analysis with the
SBP. This region, 10q24-q26, has been identified as a region
of significant linkage by univariate analyses of several
atherosclerosis traits,28 therefore supporting the hypothesis of
Table 2. Significant (LOD >3.0; Bold) and Suggestive (LOD >2.0) LOD Scores and Locations (on Marshfield Map, Markers) Between






PP SBP DBP PP
1 3.82/3.62* (200; D1S196–D1S1619) 3.07/3.14* (203; D1S196–D1S1619) 3.19/3.40* (200; D1S196–D1S1619)
10 2.41/2.35* (15; D10S1435–D10S189)
15 2.72/2.71* (94; D15S116–D15S652)
*LOD values were calculated from a smaller cohort, which excluded 55 subjects with hypertension.
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a small vessel-mediated origin of subcortical HWM. We did
not interpret the lack of the statistically significant linkage
between subcortical HWM volume and SBP as an indication
that hypertension does not play a role in the formation of the
subcortical HWM lesions. The pathogenesis of subcortical
HWM lesion is more complex because several additional
factors, including age-related, free-radical damage to oligo-
dendrocytes, and immune system-mediated gliosis, were
shown to contribute to the formation of subcortical le-
sions10,29,30 and these factors can reduce the sensitivity of
HWM SBP analysis. Further investigations that include BP
measurements in conjunction with systemic markers of infla-
tion, as proposed by Alzheimer’s Disease Neuroimaging
Initiative,31 will be necessary to help identify the genetic
factors contributing to individual risks of this complex trait.
Limitation
A limitation of this analysis is the coarse, 10 to 15 cM,
chromosomal sampling of microsatellite markers. We are in
the process of completing a high-density single nucleotide
polymorphism analysis in this population. This step will
reduce the search space to approximately 500 kb of sequence
and further refine to locations of genetic loci.
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Childhood Posterior Circulation Arterial Ischemic Stroke
Mark T. Mackay, MBBS, FRACP; Sanjay P. Prabhu, MBBS, FRCR; Lee Coleman, MBChB, BSc, FRANZCR
背景和目的：目前关于儿童后循环动脉缺血性卒中 (PCAIS) 的相关研究报道有限，本研究通过对儿童后循环动脉卒中的
临床表现、影像学特点进行分析，探讨儿童与成人 PCAIS 在梗死部位、血管畸形情况、危险因素及卒中亚型等方面的差异。
方法：收集 2002 年 8 月至 2008 年 2 月在皇家儿童医院 73 例经影像学证实的儿童 PCAIS 患者临床资料进行前瞻性研究，
应用成人血管定位分类系统，依据后循环梗死部位，将患儿分成近段组、中段组、远段组，同时血管畸形依据畸形部位、
严重程度及随时间进展情况分别进行阐述分析。应用针对儿科改良版的 TOAST 分型方法对儿童 PCAIS 进行卒中亚型分型。
结果：本组募集到的 73 例儿童病例，确定 PCAIS 27 名 (37%)，影像学上可见 34 个病灶，其中动脉病变部位近段 25 例，
中段 2 例，远段 1 例，多节段 6 例；血管事件中 14 个累及单病灶，20 个累及多病灶。25 名 PCAIS 患儿中 16 例 MRA
发现异常，其中动脉狭窄 8 例，动脉闭塞 8 例。该 16 例患儿经过 12 个月的随访调查结果显示：血管病变进展者 5 例，
暂时进展后稳定者 2 例，血管稳定或改善者 8 例，恢复正常者 1 例。25 名 PCAIS 患儿按卒中亚型分类，非进展的脑血
管狭窄闭塞动脉病 9 例，心源性栓塞 4 例，动脉夹层剥离 3 例，烟雾样血管病 3 例，其他明确病因者 4 例，可能病因 1
例以及 3 例不明原因者。52% 的儿童 PCAIS 有再发后循环 (6 例 ) 或前循环梗死 (8 例 )。
结论：非进展动脉病是儿童 PCAIS 最常见病因，常会累及后循环动脉的远段。动脉粥样硬化相关危险因素并非儿童
PCAIS 的重要原因，而儿童 PCAIS 存在高复发率。
关键词：动脉病，心源性，儿童，病因，梗死，后循环，危险因素，卒中，椎基底动脉
(Stroke. 2010;41:2201-2209.　南京军区福州总医院神经内科  吴银燕 译  殷红兵 校 )
全脑及局部性脑白质高信号体积与血压：
二变量全基因组连锁分析显示的遗传位点重叠
Whole Brain and Regional Hyperintense White Matter Volume and Blood Pressure
Overlap of Genetic Loci Produced by Bivariate, Whole-Genome Linkage Analyses
Peter Kochunov, PhD; David Glahn, PhD; Jack Lancaster, PhD; Anderson Winkler, MD; Jack W. Kent, Jr, PhD; 
Rene L. Olvera, MD; Shelley A. Cole, PhD; Thomas D. Dyer, PhD;Laura Almasy, PhD; Ravi Duggirala, PhD; 
Peter T. Fox, MD; John Blangero, PhD
背景和目的：脑白质 T2 高信号 (HWM) 体积是大脑完整性的重要的神经影像学标志，且有高度遗传性。病理生理学研究
已显示局部、室管膜及皮层下的 HWM 损害分别与脉压和动脉血压相关。我们通过对健康墨西哥裔美国人的 HWM 体积
和血压进行二变量全基因组连锁分析，以确定其与两者相关的染色体区域。我们的目的是明确这些表型新的基因多向性
定量性状位点，并复制之前在全脑 HWM 体积和血压测量中遗传学的发现。
方法：血压测量以及高分辨率 (1 mm3) 三维液体衰减反转恢复 (FLAIR) 成像测得的全脑、皮层下及室管膜的 HWM 病损体积作
为局部定量表型。数据收集于San Antonio Family Heart研究中多个扩大家庭的357位成员 (218位女性；平均年龄47.9±13.2 岁 )。 
结果：二变量全基因组连锁分析确定了影响全脑及局部（室管膜）的 HWM 体积及脉压和收缩压的有意义的定量性状位点，
在染色体位置 1q24 的标志物 D1S196 和 D1S1619 之间。几个其他染色体区域（1q42, 10q24-q26 和 15q26）显示可能的关
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